Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program

Michael S. Epstein, Eric D. Shah, Parakkal Deepak, Vladimir M. Kushnir

Research output: Contribution to journalComment/debate

1 Scopus citations

Fingerprint

Dive into the research topics of 'Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program'. Together they form a unique fingerprint.